Insider · CIK 0001995009
Jenny Robertson
Files at LXEO (Lexeo Therapeutics, Inc.). First filing May 20, 2025, latest Nov 20, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LXEO: Lexeo Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Lexeo Therapeutics, Inc. | $5,089 549 shares | -1% | +413% from low-9% from high | |
| 35Weak | Lexeo Therapeutics, Inc. | $32k 3,526 shares | -5% | +435% from low-14% from high | |
| 30Weak | Lexeo Therapeutics, Inc. | $2,530 542 shares | -1% | +175% from low-56% from high | |
| 30Weak | Lexeo Therapeutics, Inc. | $1,445 521 shares | -1% | +81% from low-71% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -549 | $9.27 | $5,089 | 68,381 | Nov 20, 2025 |
| Oct 15, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +9,900 | $0.00 | $0 | 72,456 | Oct 17, 2025 |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -3,486 | $8.94 | $31k | 68,970 | Oct 17, 2025 |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -40 | $9.56 | $382 | 68,930 | Oct 17, 2025 |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -542 | $4.67 | $2,530 | 62,556 | Aug 20, 2025 |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -521 | $2.77 | $1,445 | 63,098 | May 20, 2025 |
| Mar 14, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +5,720 | $2.61 | $15k | 63,619 | Apr 9, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.